A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
Clinical trial NCT07302256 · RECRUITING
Trial details
- NCT number
- NCT07302256
- Sponsor
- Shanghai Institute Of Biological Products
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-16
- Primary completion
- 2026-08-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.